CRMDCorMedix Inc.

$536M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$51,862

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.17

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$91M

Total Liabilities

$8M

Stockholders' Equity

$83M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$6,817	-100.0%
Gross Profit	-$51,862	$5,348	-1069.7%
Operating Income	-$10M	-$7M	-50.4%
Net Income	-$10M	-$7M	-42.2%

CRMD Q3 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena